Acute neuropathy refers to a rapid-onset dysfunction of the peripheral nervous system, often manifesting as weakness, numbness, or pain. It can be a medical emergency, especially when associated with rapid progression, autonomic instability, or respiratory compromise. Prompt recognition and intervention are essential to prevent long-term disability or death.

Neftaly’s Acute Care Protocol for Acute Neuropathy provides healthcare professionals with an evidence-based framework for the timely assessment, diagnosis, and management of acute neuropathic conditions in both adults and children.

---

1. Understanding Acute Neuropathy

Definition:

Acute neuropathy is a sudden-onset disturbance in peripheral nerve function. It may affect motor, sensory, or autonomic fibers and can be caused by:

• Immune-mediated (e.g., Guillain-Barré Syndrome)
• Toxic (e.g., heavy metal exposure, drug-induced)
• Infectious (e.g., viral neuropathies like HIV or herpes)
• Metabolic (e.g., acute diabetic neuropathy)
• Nutritional deficiencies (e.g., thiamine or B12 deficiency)

---

2. Initial Clinical Assessment

A. Primary Survey (ABCs)

• Airway: Assess for bulbar dysfunction (difficulty swallowing, risk of aspiration).
• Breathing: Look for signs of diaphragmatic weakness (shallow breathing, use of accessory muscles).
• Circulation: Monitor for arrhythmias or autonomic instability (sudden BP or HR changes).

B. Focused Neurological Assessment

• Motor Strength Testing: Graded from 0 (no movement) to 5 (normal strength).
• Sensory Exam: Light touch, pinprick, proprioception, and vibration.
• Reflexes: Decreased or absent deep tendon reflexes are common in neuropathy.
• Cranial Nerves: Check for facial weakness, ophthalmoplegia, or dysarthria.
• Autonomic Signs: Fluctuating BP, arrhythmias, urinary retention.

---

3. Common Acute Neuropathies and Neftaly Response

A. Guillain-Barré Syndrome (GBS)

• Presentation: Ascending weakness, areflexia, paresthesias, possible respiratory failure.
• Neftaly Intervention:
  • Admit to high-dependency or ICU setting.
  • Monitor respiratory function (vital capacity, NIF).
  • Initiate IVIG (0.4 g/kg/day x 5 days) or plasmapheresis.
  • DVT prophylaxis, pain control, and supportive care.

B. Acute Diabetic Neuropathy

• Presentation: Sudden severe burning pain, often at night, with sensory loss.
• Neftaly Intervention:
  • Optimize glycemic control.
  • Pain management (gabapentin, pregabalin, amitriptyline).
  • Rule out alternative causes if atypical.

C. Infectious Neuropathies

• Examples: HIV neuropathy, Lyme disease, diphtheria-associated neuropathy.
• Neftaly Intervention:
  • Treat underlying infection (antivirals, antibiotics).
  • Supportive care and symptomatic treatment.

D. Toxin-Induced Neuropathy

• Examples: Chemotherapy (e.g., vincristine), heavy metals, alcohol.
• Neftaly Intervention:
  • Remove exposure.
  • Chelation therapy (if applicable).
  • Supportive neurology and pain management.

---

4. Diagnostic Workup

Laboratory Tests:

• CBC, ESR/CRP
• Blood glucose and HbA1c
• Renal and liver function
• Vitamin B12, folate, and thiamine levels
• Viral serologies (e.g., HIV, CMV, EBV)
• Toxin screens if indicated

Neurophysiological Studies:

• Nerve Conduction Studies (NCS) and Electromyography (EMG): Differentiate between demyelinating vs. axonal neuropathy.

Cerebrospinal Fluid (CSF) Analysis:

• Indicated in suspected GBS: Look for albuminocytologic dissociation (elevated protein, normal WBC count).

---

5. Respiratory Monitoring and Support

• Vital capacity and negative inspiratory force monitoring every 4-6 hours in progressive cases.
• Prepare for intubation if:
  • VC < 20 mL/kg
  • NIF < -30 cm H2O
  • Rapid progression of weakness
• Consider ICU admission for any signs of respiratory compromise or autonomic dysfunction.

---

6. Autonomic and Pain Management

Autonomic Instability:

• Continuous cardiac monitoring.
• Treat bradycardia/tachycardia, hypertension/hypotension symptomatically.
• Avoid medications that can worsen autonomic symptoms.

Neuropathic Pain Management:

• First-line: Gabapentin, pregabalin, tricyclic antidepressants.
• Adjuncts: Topical agents (lidocaine), NSAIDs (for associated inflammation), opioids (short-term only).

---

7. Rehabilitation and Disposition Planning

• Begin early physiotherapy and occupational therapy to prevent contractures and promote mobility.
• Speech therapy if bulbar involvement is present.
• Psychological support for anxiety or depression related to functional loss.
• Discharge planning should include:
  • Follow-up with neurology
  • Home care support
  • Continued rehab services

---

8. Family and Patient Education

• Provide clear information about:
  • Diagnosis and expected course
  • Red flags for worsening (difficulty breathing, severe weakness)
  • Importance of follow-up and medication adherence
• Involve family in care decisions and support services.

---

9. Multidisciplinary Coordination

• Work closely with:
  • Neurology
  • Intensive care
  • Physical and occupational therapy
  • Psychology or psychiatry
  • Social work and discharge planning

---

10. Conclusion

Acute neuropathy can be rapidly disabling and even life-threatening. The Neftaly Acute Care Protocol ensures that healthcare providers are equipped to recognize early signs, initiate appropriate interventions, and coordinate comprehensive care for patients experiencing acute neuropathic syndromes.